Absci Corp
ABSIHealthcare|Biotechnology|USA
$10.60
-0.87 (-7.59%)
Tangible Book
$0.85
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07317544 Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia | Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female | P1P2 | Recruiting | 227 | RCT, Double-blind | ABS-201 IV Single Dose, Placebo IV, ABS-201 SC Multiple Doses, Placebo SC Injection |